Siemens Healthineers AG

Jefferies Reaffirms Buy Rating on Siemens Healthineers with €50 Target

Siemens Healthineers and Yanghe Medical Sign Photon Counting CT Cooperation Agreement

Siemens Healthineers Reports Q2 2026 Earnings and Updates Full-Year Guidance

Barclays Analyst Maintains Buy Rating on Siemens Healthineers

ScreenPoint Completes B Round Financing to Accelerate AI Breast Cancer Screening Technology Promotion

Siemens Healthineers VARIAN TRUEBEAM Receives FDA Approval for Low-Dose Radiation Therapy

RBC Capital Analyst Maintains Buy Rating on Siemens Healthineers

Siemens Healthineers to Showcase AI Innovations at 2026 Dubai Expo

Siemens Healthineers Reports Exceeding Q1 Operating Profit but Failing Revenue Expectations

Azra AI has appointed Jessica Turgon, a recognized oncology strategist, to its Board of Directors. Turgon brings extensive experience in oncology growth and operational transformation, having previously worked with Siemens Healthineers and ECG Management Consultants. Her expertise will support Azra AI's mission to enhance cancer care coordination through AI-driven solutions, addressing critical challenges in healthcare today.

prnewswire

09:03 ETAzra AI Appoints Oncology Leader Jessica Turgon to Board of Directors

Jefferies analyst Julien Dormois has reaffirmed a Buy rating for Siemens Healthineers AG (SEMHF) with a price target of €50.00. Despite Dormois's average return of -13.1% and a 28.57% success rate, the stock also received a Buy rating from Bernstein's Susannah Ludwig. Conversely, Goldman Sachs maintained a Hold rating on the company.

Tip Ranks

Jefferies Financial

AllianceBernstein

Goldman Sachs

GS Hldg R

Jefferies Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)

SIEGY

Jefferies analyst Rizk Maidi has reaffirmed a Buy rating on Siemens, setting a price target of €277.00. Maidi, a 4-star analyst with a 68% success rate, follows Bernstein's Alasdair Leslie, who also issued a Buy rating today. In contrast, Kepler Capital maintained a Sell rating on Siemens on May 11.

Siemens

Siemens AG

Jefferies Keeps Their Buy Rating on Siemens (0P6M)

Siemens Healthineers (XTRA:SHL) has partnered with HKSH Medical Group to establish HKSH as Asia's first Photon Counting CT Simulator Reference Site, enhancing its radiotherapy technology presence. Despite this collaboration, the stock has seen a 10.25% decline over the past month and a 23.20% drop year-to-date. Analysts suggest a fair value of €53.47 per share, indicating the stock is undervalued at its current price of €33.90. The company faces risks from tariff pressures and market conditions in China, which could impact its growth narrative.

Simplywall

A Look At Siemens Healthineers (XTRA:SHL) Valuation After New HKSH Photon‑Counting CT Partnership

6869

SSMXY

The Hematology Analyzers and Reagents Market is projected to grow from USD 7.57 billion in 2026 to USD 10.33 billion by 2031, at a CAGR of 6.4%. The Asia Pacific region is expected to witness the highest growth rate, driven by increasing demand for advanced diagnostic tools and rising prevalence of blood-related diseases. The blood cancer segment is anticipated to dominate the market, accounting for 34% of revenue share in 2025. Key players include Sysmex Corporation, Danaher Corporation, and Siemens Healthineers.

Sysmex Corporation

Sysmex

Danaher

10:15 ETHematology Analyzers and Reagents Market worth $10.33 billion by 2031 | MarketsandMarkets™

SHEL.WI

RDSB

SHEH

XSER

European shares fell on May 7, with the pan-European Stoxx 600 down 1.1% after a previous rally, as investors evaluated a potential US-Iran peace deal that pressured crude prices below $100 a barrel. Energy stocks dropped 2.5%, and Shell lost 2.9% despite strong earnings. Campari's shares plummeted 14.5% after missing revenue expectations, while Siemens Healthineers fell 4.7% due to a lowered outlook. The European Central Bank noted progress in eurozone financial integration, but equity markets remain fragmented amid ongoing geopolitical uncertainties.

Businesstimes News

Shell PLC

Royal Dutch Shell Plc Class B

Shell plc ADRhedged

Xtrackers STOXX EUROPE 600 OIL & GAS UCITS ETF Capitalisation 1C

Shell

Pernod Ricard SA

Diageo plc

Diageo

Rheinmetall AG

Henkel AG & Co. KGaA Pref

RHEINMETALL AG UNSP ADR EACH REPR 0.2 ORD

Henkel AG & Co. KGaA

European shares pull back as Middle East peace prospects assessed

Siemens Healthineers has revised its 2026 financial outlook, now projecting revenue growth of 4.5% to 5.0%. This adjustment is attributed to structural changes in the Chinese Diagnostics market and increased inflation expectations. The Chinese market represents approximately 10% of the company's total revenue.

Siemens Healthineers cuts 2026 outlook

Siemens Healthineers AG(SHL.DE)